New Astra Pill Shows Promise in Rapidly Lowering Hard-to-Control Blood Pressure
TL;DR Summary
AstraZeneca's experimental hypertension drug, baxdrostat, significantly lowers blood pressure more than standard treatments in a late-stage trial, with regulatory approval expected soon, potentially transforming treatment for resistant hypertension.
- Astra Pill Cuts Hard-to-Treat Blood Pressure in Late-Stage Trial Bloomberg.com
- There may soon be a new approach to treat hard-to-control high blood pressure CNN
- New drug hailed as ‘gamechanger’ in tackling stubbornly high blood pressure The Guardian
- New blood pressure pill ‘lowers risk of heart problems in 12 weeks’ The Independent
- Stubborn high blood pressure drops with an experimental drug that targets hormone imbalance Medical Xpress
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
3 min
vs 3 min read
Condensed
95%
595 → 28 words
Want the full story? Read the original article
Read on Bloomberg.com